N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide

C18H30N2O2 — CID 3344892

IUPACN-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide
SMILESCC(NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)NC(C)(C)C
InChIInChI=1S/C18H30N2O2/c1-11(15(21)20-17(2,3)4)19-16(22)18-8-12-5-13(9-18)7-14(6-12)10-18/h11-14H,5-10H2,1-4H3,(H,19,22)(H,20,21)
InChIKeyUEXHBQVNKLKXRA-UHFFFAOYSA-N
MW306.45 g/mol
LogP2.62
Rot. Bonds3

About N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide

N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide (PubChem CID 3344892) has the molecular formula C18H30N2O2 and a molecular weight of 306.45 g/mol. Its IUPAC name is N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide.

Molecular Properties

Compound NameN-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide
PubChem CID3344892
Molecular FormulaC18H30N2O2
Molecular Weight306.45 g/mol
Exact Mass306.23
IUPAC NameN-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide
SMILESCC(NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)NC(C)(C)C
InChIInChI=1S/C18H30N2O2/c1-11(15(21)20-17(2,3)4)19-16(22)18-8-12-5-13(9-18)7-14(6-12)10-18/h11-14H,5-10H2,1-4H3,(H,19,22)(H,20,21)
InChIKeyUEXHBQVNKLKXRA-UHFFFAOYSA-N
XLogP2.62
TPSA58.20 Ų
H-Bond Donors2
H-Bond Acceptors2
Rotatable Bonds3
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500306.45
LogP ≤ 52.62
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 102

Analyze N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(2R)-1-(methylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide
CID 7432877
N-[(2R)-1-hydrazinyl-1-oxopropan-2-yl]adamantane-1-carboxamide
CID 7090487
1-[[1-(tert-butylamino)-1-oxopropan-2-yl]carbamoyl]cyclobutane-1-carboxylic acid
CID 113408093
(5R,7R)-N-[(2R)-1-(tert-butylamino)-1-oxopropan-2-yl]-3-(4-methylphenyl)adamantane-1-carboxamide
CID 98427691
N-[(2S)-1-[2-(tert-butylcarbamothioyl)hydrazinyl]-3-methyl-1-oxobutan-2-yl]adamantane-1-carboxamide
CID 9425931
N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-2-carboxamide
CID 47798207
N-[1-(4-methylanilino)-1-oxopropan-2-yl]adamantane-1-carboxamide
CID 5229641
N-[(1R)-1-(1-adamantyl)ethyl]adamantane-1-carboxamide
CID 7065184
N-[(2S)-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]adamantane-1-carboxamide
CID 7149964
N-[(2R)-1-(4-iodoanilino)-1-oxopropan-2-yl]adamantane-1-carboxamide
CID 29404544
N-[(2R)-1-oxo-1-[(5-propan-2-yl-1,3,4-thiadiazol-2-yl)amino]propan-2-yl]adamantane-1-carboxamide
CID 25481046
N-[(2S)-1-(3-bromoanilino)-1-oxopropan-2-yl]adamantane-1-carboxamide
CID 9038662

Frequently Asked Questions

What is the IUPAC name of N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide?
The IUPAC name of N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide (CID 3344892) is N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide.
What is the SMILES notation for N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide?
The canonical SMILES for N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide is CC(NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)NC(C)(C)C.
What is the InChIKey of N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide?
The InChIKey is UEXHBQVNKLKXRA-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H30N2O2/c1-11(15(21)20-17(2,3)4)19-16(22)18-8-12-5-13(9-18)7-14(6-12)10-18/h11-14H,5-10H2,1-4H3,(H,19,22)(H,20,21).
What are the key properties of N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide?
N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide has a molecular weight of 306.45 g/mol, XLogP of 2.62, 3 rotatable bonds, 2 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(tert-butylamino)-1-oxopropan-2-yl]adamantane-1-carboxamide is sourced from PubChem (CID 3344892), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).